Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$391M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$370M |
| 3 |
CPN
Calpine Corporation
CPN
|
+$359M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$269M |
| 5 |
Gilead Sciences
GILD
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.08B |
| 2 |
Home Depot
HD
|
+$425M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$329M |
| 4 |
Wells Fargo
WFC
|
+$237M |
| 5 |
Vodafone
VOD
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.8% |
| 2 | Technology | 4.73% |
| 3 | Financials | 4.42% |
| 4 | Communication Services | 3.81% |
| 5 | Real Estate | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
CALL
ScottsMiracle-Gro
SMG
$3.66B
| $488K | ﹤0.01% |
8,000
+7,500
| +1,500% | +$445K |
|
|
DBD
3902
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
| $488K | ﹤0.01% |
12,500
-1,800
| -13% | -$64.8K |
|
|
ALU
3903
CALL
DELISTED
Alcatel-Lucent
ALU
| $488K | ﹤0.01% |
162,700
+2,700
| +2% | +$11.2K |
|
3904
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $487K | ﹤0.01% |
12,577
-1,264
| -9% | -$48.3K |
|
|
KOL
3905
PUT
DELISTED
VanEck Vectors Coal ETF
KOL
| $486K | ﹤0.01% |
2,700
+1,100
| +69% | +$198K |
|
3906
PUT
AngloGold Ashanti
AU
$48.7B
| $485K | ﹤0.01% |
28,500
-44,800
| -61% | -$712K |
|
3907
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $485K | ﹤0.01% |
4,800
+2,500
| +109% | +$254K |
|
3908
CALL
RenaissanceRe
RNR
$13.4B
| $485K | ﹤0.01% |
5,000
+4,800
| +2,400% | +$450K |
|
3909
Icahn Enterprises
IEP
$5.3B
| $484K | ﹤0.01% |
4,742
+2,333
| +97% | +$257K |
|
|
DANG
3910
PUT
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $484K | ﹤0.01% |
34,600
-14,000
| -29% | -$168K |
|
3911
HNI Corp
HNI
$3.59B
| $483K | ﹤0.01% |
13,409
-28,836
| -68% | -$1.03M |
|
3912
United States Oil Fund
USO
$1.84B
| $482K | ﹤0.01% |
1,673
-62,573
| -97% | -$17.7M |
|
|
CRR
3913
PUT
DELISTED
Carbo Ceramics Inc.
CRR
| $480K | ﹤0.01% |
3,500
-117,200
| -97% | -$13.9M |
|
|
CHTP
3914
CALL
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $480K | ﹤0.01% |
95,900
+68,900
| +255% | +$346K |
|
|
SPLS
3915
CALL
DELISTED
Staples Inc
SPLS
| $480K | ﹤0.01% |
43,600
-67,200
| -61% | -$878K |
|
3916
CALL
Invesco DB Agriculture Fund
DBA
$1.23B
| $479K | ﹤0.01% |
17,100
-17,900
| -51% | -$470K |
|
3917
Gogo Inc
GOGO
$493M
| $478K | ﹤0.01% |
23,900
-184,167
| -89% | -$4.06M |
|
3918
Prestige Consumer Healthcare
PBH
$2.6B
| $478K | ﹤0.01% |
17,707
-100,930
| -85% | -$3M |
|
|
HIBB
3919
PUT
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $478K | ﹤0.01% |
9,200
+8,100
| +736% | +$478K |
|
3920
CALL
Cullen/Frost Bankers
CFR
$10.2B
| $477K | ﹤0.01% |
6,200
+5,000
| +417% | +$374K |
|
3921
CALL
Markel Group
MKL
$23.2B
| $477K | ﹤0.01% |
+800
| New | +$456K |
|
|
3922
PUT
Markel Group
MKL
$23.2B
| $477K | ﹤0.01% |
+800
| New | +$456K |
|
|
CZZ
3923
DELISTED
Cosan Limited
CZZ
| $477K | ﹤0.01% |
43,409
+27,428
| +172% | +$327K |
|
3924
Corcept Therapeutics
CORT
$12B
| $476K | ﹤0.01% |
119,004
+117,822
| +9,968% | +$412K |
|
|
SPLK
3925
CALL
DELISTED
Splunk Inc
SPLK
| $476K | ﹤0.01% |
6,700
-13,100
| -66% | -$1.07M |
|
Similar funds
Barclays's Q1 2014 Portfolio in Review
As of Q1 2014, Barclays held 8,036 positions worth $88.3B, down 9.5% from $97.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $11.2B in Q1 2014, closing 382 positions and reducing 4,029 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $136M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 5.8% of assets, up from 5.2% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in LIN MEDIA LLC CLASS A COM worth $23.4M.
- Barclays's largest Q1 2014 buy was LIN MEDIA LLC CLASS A COM: 898,200 shares worth $23.4M.
- Barclays added most to State Street SPDR S&P Retail ETF in Q1 2014, an estimated $391M increase.
- Barclays's biggest Q1 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.08B.
- Barclays fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $136M.
- Barclays's ten largest holdings make up 22% of its $88.3B portfolio in Q1 2014.
- Barclays opened 459 new positions and closed 382 in Q1 2014.
- Barclays's portfolio value fell 9.5% quarter-over-quarter to $88.3B.
Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.